Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
European Journal of Immunology|October 3, 1999
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRnJ K Kim, M Firan, C G Radu, et al.European Journal of Immunology|March 1, 1996
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient miceV Ghetie, J G Hubbard, J K Kim, et al.International Immunology|October 24, 1998
Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of miceJ Borvak, J Richardson, C Medesan, et al.Nature Biotechnology|July 1, 1997
Increasing the serum persistence of an IgG fragment by random mutagenesisV Ghetie, S Popov, J Borvak, et al.International Immunology|July 27, 2001
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humansM Firan, R Bawdon, C Radu, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administrationR M Conry, M B Khazaeli, M N Saleh, et al.Leukemia|January 19, 2000
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxinR Schnell, E Vitetta, J Schindler, et al.Leukemia & Lymphoma|August 26, 1998
Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphomaR Schnell, E Vitetta, J Schindler, et al.Science (New York, N.Y.)|November 25, 1988
HIV-infected cells are killed by rCD4-ricin A chainM A Till, V Ghetie, T Gregory, et al.Blood|November 1, 1993
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapyP L Amlot, M J Stone, D Cunningham, et al.Pageof 8